Valuation: Kenvue Inc.

Market Cap 36.88B 31.88B 29.99B 27.25B 51.16B 3,519B 52.06B 351B 137B 1,764B 138B 135B 5,878B P/E 2026 *
20.2x
P/E 2027 * 17.8x
Enterprise Value 43.94B 37.99B 35.74B 32.47B 60.96B 4,193B 62.04B 418B 163B 2,102B 165B 161B 7,004B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.72x
Free-Float
98.88%
Yield 2026 *
4.41%
Yield 2027 * 4.49%
1 week-0.16%
Current month-0.21%
1 month+2.67%
3 months+12.22%
6 months+2.67%
Current year+11.30%
1 week 18.65
Extreme 18.65
19.31
1 month 18.65
Extreme 18.65
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.84
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.16%-9.43%-17.45% 36.88B
+0.20%-0.85%-6.36%-6.62% 336B
-0.84%-1.72%-9.02%+0.75% 134B
-1.05%-1.42%+8.09%+23.19% 73.3B
-0.72%-0.91%-16.27%-18.01% 51.04B
-1.40%-2.55%-5.35%-47.35% 31.15B
-0.67%-3.31%+6.61%+22.87% 20.09B
+0.29%-1.42%+12.36%+7.00% 19.82B
-0.33%-3.55%-23.06%-35.22% 19.77B
-0.28%-11.02%-21.15%-9.78% 10B
Average -0.48%-2.63%-6.36%-8.06% 73.19B
Weighted average by Cap. -0.30%-1.72%-5.99%-4.99%

Financials

2026 *2027 *
Net sales 15.6B 13.48B 12.68B 11.52B 21.64B 1,488B 22.02B 148B 58.02B 746B 58.53B 57.28B 2,486B 15.97B 13.81B 12.99B 11.8B 22.15B 1,524B 22.54B 152B 59.4B 764B 59.93B 58.65B 2,545B
Net income 1.83B 1.58B 1.49B 1.35B 2.54B 175B 2.59B 17.43B 6.82B 87.62B 6.88B 6.73B 292B 2.09B 1.8B 1.7B 1.54B 2.89B 199B 2.94B 19.84B 7.76B 99.73B 7.83B 7.66B 332B
Net Debt 7.07B 6.11B 5.75B 5.22B 9.8B 674B 9.97B 67.23B 26.28B 338B 26.52B 25.95B 1,126B 6.59B 5.7B 5.36B 4.87B 9.14B 629B 9.3B 62.71B 24.51B 315B 24.73B 24.2B 1,050B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-14 US$19.20 0.00% 10,361,710
26-08-13 US$19.20 +1.16% 17,042,522
26-08-12 US$18.98 -0.37% 11,026,140
26-08-11 US$19.05 +0.11% 12,782,165
26-08-10 US$19.03 -1.04% 25,550,069
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.20USD
Average target price
19.50USD
Spread / Average Target
+1.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock